IMPROVE PATIENT
RECRUITMENT & RETENTION
WITH EARLY PLANNING

We give you access to real-world insights to better inform decision making and improve study planning, with a focus on patient eligibility and enrolment rates at a site level

If you have a candidate that’s ready for a phase III clinical study, you’ve already invested a lot of time, effort and money. However, without early planning driven by important patient and stakeholder insight, your drug development journey can often be even more costly. And there-in lies your biggest challenge.

 

While you might be confident in your drug’s potential, in order to reach your study’s enrolment targets, you now need to persuade many others who will each need communicating with in different ways.

To know how to best communicate your drug’s potential to your different audiences, you first need to listen to what those who you’re targeting have to say. This means speaking with:

+  patient groups

+  investigators

+  healthcare professionals

+  patients

You can then develop recruitment and retention plans that meet both the regulatory and scientific requirements of the study, as well as capturing the attention of prospective sites and participants.

COMMUNICATING YOUR DRUG'S POTENTIAL

The importance of patient and stakeholder insights

Only 6% of patients believe that biopharma companies are on their side; many are convinced that companies aren’t developing treatments for people, but for commercial gain. This lack of trust makes engaging and ultimately persuading people to join your study a difficult task. But this is where insight at the early planning stage can help.

 

Gaining insights from patients and other stakeholders allows you to tailor your study design and recruitment campaign to the people you’re targeting. Insights help your understanding of their barriers, concerns, misconceptions, wants and needs – enabling you to address them early on. This clear understanding of your target audience will help you to create a strong plan, ultimately leading to a successful clinical study.

The benefits of stakeholder insights in early planning are clear:

Improved protocol

compliance by sites

Enhanced clinical

study experiences for

sites and patients

Accelerated clinical

study timelines

Tools for smart, insightful strategies

Successful early planning requires a smart, insightful, human-focused approach. From patient recruitment and retention strategies to patient engagement campaigns, we’re experts in knowing where and how to engage with real people, on a real level.

Patient experience mapping

Market research

Market research

Social listening

Mock
clinical study simulations

Recruitment feasibility

Patient group advocacy

CLINICAL STUDY PATIENT RECRUITMENT & RETENTION PLANNING SERVICES WE OFFER INCLUDE:

While establishing a lead drug candidate is a considerable achievement and having a big budget can be helpful, unless enrolment targets are met, your clinical study faces costly delays, or worse, will fail.

 

Insightful, early planning can help you stand out from the many other clinical studies also looking to recruit participants and persuade stakeholders. Your communications will prove that you understand their thoughts and feelings, and focus on what they need to know.

 

If you’d like to hear more about our patient recruitment and retention planning services, or would like to discuss how we can guide early planning in your clinical studies, contact us today.

START EARLY AND STAND OUT

COUCH Health Communications logo – white